IOL Pharma Secures EcoVadis Silver Medal for Boosting Green Practices

IOL Chemicals and Pharmaceuticals Limited has been honored with a Silver Medal by EcoVadis, achieving a creditable score of 71 and obtaining a position in the 89th percentile among companies evaluated worldwide.

Orion Partners with Shilpa Medicare for Albumin Supply Deal

Shilpa Biocare, an integral Shilpa Medicare subsidiary, has signed a commercial supply contract across Europe with Orion Corporation for its recombinant human albumin, ahead of the Bio International Bio Convention in Boston.

Parexel Secures CDSCO Approval Under G.S.R 581(E) Guidelines

Parexel, a top-ranked international clinical research organisation (CRO), has formally registered with India's Central Drugs Standard Control Organisation (CDSCO), in line with the newly imposed G.S.R 581(E) regulation.

Minimum Import Price Policy Aims to Boost Domestic Pharma Resilience

India is considering imposing a Minimum Import Price (MIP) on critical components of medicines to cut the country's dependence on costlier Chinese imports and spur local production.

Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India

Glenmark Pharmaceuticals has announced that it will shortly introduce zanubrutinib in India, soon after getting its recent approval from the Drugs Controller General of India (DCGI).

Lupin Gets Approval from USFDA for Oxcarbazepine ER Tablets

Lupin Limited has obtained approval from the USFDA for its 150 mg, 300 mg, and 600 mg strength Oxcarbazepine ER tablets.

India Gets Targeted IDH1 Therapy as Servier Rolls Out Ivosidenib

Servier India, the Indian subsidiary of French multinational pharmaceutical company Servier Group, has rolled out Ivosidenib, an oral targeted treatment for IDH1-mutated acute myeloid leukaemia

NPPA Regulates 41 Drug Combinations to Curb Healthcare Costs

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price ceilings on 41 combinations of drugs, including 18 types of Boehringer Ingelheim's

Biocon Received Approval in India for its Liraglutide Drug Substance

Biocon Limited, a global biopharmaceutical company focused on innovation, announced today that its Liraglutide drug substance has been approved in India. In addition, Biocon Pharma Limited, a wholly...

Andhra Pradesh Issues Covid-19 Warning, Urges Precautions

Amid the renewed surge in Covid-19 cases across the country, Andhra Pradesh Information and Public Relations Minister K Parthasarathi on Sunday called on citizens to stay alert and follow precautionary guidelines...

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.